National Health (Prescriber bag supplies) Amendment Determination 2020 (No. 4) (PB 92 of 2020) (Cth)
PB 92 of 2020
National Health (Prescriber bag supplies) Amendment Determination 2020 (No. 4)
National Health Act 1953
___________________________________________________________________________
I, THEA CONNOLLY, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Instrument under sections 93 and 93AB of the National Health Act 1953.
Dated 28 September 2020
THEA CONNOLLY
Assistant Secretary
Pricing and PBS Policy Branch
Technology Assessment and Access Division
Department of Health
___________________________________________________________________________
Name of Determination
(1)This Determination is the National Health (Prescriber bag supplies) Amendment Determination 2020 (No. 4).
(2)This Determination may also be cited as PB 92 of 2020.
Commencement
This Determination commences on 1 October 2020.
Amendment of National Health (Prescriber bag supplies) Determination 2012
Schedule 1 amends the National Health (Prescriber bag supplies) Determination 2012 (PB 73 of 2012).
Schedule 1 Amendments
Schedule,
omit table and substitute:
| Group Number | Listed Drug | Form | Prescriber Bag Supplier | Maximum Quantity |
| 1 | Adrenaline (epinephrine) | Injection 1 mg (as acid tartrate) in 1 mL (1 in 1,000) | MP, NP | 5 |
| 3 | Atropine | Injection containing atropine sulfate monohydrate 600 micrograms in 1 mL | MP, NP | 10 |
| 58 | Benzathine benzylpenicillin | Injection containing 1,200,000 units benzathine benzylpenicillin tetrahydrate in 2.3 mL single use pre‑filled syringe | MP, NP | 10 |
| 31 | Benzatropine | Injection containing benzatropine mesilate 2 mg in 2 mL | MP, NP | 5 |
| 17 | Benzylpenicillin | Powder for injection 600 mg (as sodium) | MP, NP | 5 |
| 32 | Benzylpenicillin | Powder for injection 3 g (as sodium) | MP, NP | 1 |
| 4 | Chlorpromazine | Injection containing chlorpromazine hydrochloride 50 mg in 2 mL | MP, NP | 10 |
| 34 | Clonazepam | Oral liquid 2.5 mg per mL, 10 mL | MP, NP | 1 |
| 25 | Diphtheria and tetanus vaccine, adsorbed, diluted for adult use | Injection 0.5 mL in pre‑filled syringe | MP, NP | 10 |
| 10 | Furosemide | Injection 20 mg in 2 mL | MP, NP | 5 |
| 26 | Glucagon | Injection set containing glucagon hydrochloride 1 mg (1 I.U.) and 1 mL solvent in disposable syringe | MP, NP | 1 |
| 30 | Glyceryl Trinitrate | Sublingual spray (pump pack) 400 micrograms per dose, 200 doses | MP, NP | 1 |
| 4 | Haloperidol | Injection 5 mg in 1 mL | MP, NP | 10 |
| 12 | Hydrocortisone | Injection 100 mg (as sodium succinate) with 2 mL solvent | MP, NP | 2 |
| 12 | Hydrocortisone | Injection 250 mg (as sodium succinate) with 2 mL solvent | MP, NP | 1 |
| 33 | Hyoscine | Injection containing hyoscine butylbromide 20 mg in 1 mL | MP, NP | 5 |
| 54 | Lidocaine | Injection containing lidocaine hydrochloride monohydrate 50 mg in 5 mL | MP, NP | 5 |
| 35 | Methoxyflurane | Liquid for inhalation 999 mg per g, 3 mL (with inhaler) | MP | 1 |
| 18 | Metoclopramide | Injection containing 10 mg metoclopramide hydrochloride (as monohydrate) in 2 mL | MP, NP | 10 |
| 53 | Midazolam | Injection 5 mg (as hydrochloride) in 1 mL | MP, NP | 10 |
| 14 | Morphine | Injection containing morphine hydrochloride trihydrate 10 mg in 1 mL | MP, NP | 5 |
| 14 | Morphine | Injection containing morphine hydrochloride trihydrate 20 mg in 1 mL | MP, NP | 5 |
| 14 | Morphine | Injection containing morphine sulfate pentahydrate 15 mg in 1 mL | MP, NP | 5 |
| 14 | Morphine | Injection containing morphine sulfate pentahydrate 30 mg in 1 mL | MP, NP | 5 |
| 57 | Naloxone | Injection containing naloxone hydrochloride 400 micrograms in 1 mL ampoule | MP, NP | 10 |
| 55 | Phytomenadione | Injection 10 mg in 1 mL | MP | 5 |
| 17 | Procaine benzylpenicillin | Injection 1.5 g in disposable syringe | MP, NP | 5 |
| 18 | Prochlorperazine | Injection containing prochlorperazine mesilate 12.5 mg in 1 mL | MP, NP | 10 |
| 19 | Promethazine | Injection containing promethazine hydrochloride 50 mg in 2 mL | MP, NP | 10 |
| 59 | Salbutamol | Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 20 | MP, NP | 1 |
| 59 | Salbutamol | Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 30 | MP, NP | 1 |
| 28 | Salbutamol | Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 20 | MP, NP | 1 |
| 28 | Salbutamol | Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 30 | MP, NP | 1 |
| 59 | Salbutamol | Pressurised inhalation 100 micrograms (as sulfate) per dose, 200 doses (CFC‑free formulation) | MP, NP | 1 |
| 59 | Salbutamol | Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC‑free formulation) | MP, NP | 1 |
| 16 | Tramadol | Injection containing tramadol hydrochloride 100 mg in 2 mL | MP, NP | 5 |
0
0
0